Start of new week recap Sure has been some stuff pasted last few days.
im not involve or know either, don't take personal.
Notable does post a lot if stuff, with a lot
All related somehow with Onc: in some cases requiring some thought to relate to the like.
Most of which are market/ drug/ value type of comparables.
seconded by related stories on various cancer & comparable cancer treatments.
My extraction from all that.
1. Pelareorep has shown excelent efficacy within the Pancreatic trial.
2. Pelareorep requires very little special handling. Administration is a simple I.V.pelea finds the tumour. Meaning does not need to be injected directly into the cancer. Next to impossible with mutiple locations.
3. Many pharma deals, have been done lately. Paying Billions. More than one B. and, paying that for products with a lot less.
A lot less?
oncpytics biotech has two FDA fast track approvals for cancer treatment, they have been ramping up production in need for the phase 3 trials.
So all of that in general & sometimes broader sense from Notable.
lots to read. I look deeper into the various presentations. Takes a bit of time.
Certainly deserves mor3 than the silly & variations conspiracy theories. Whic( have zero to d9 with anything. Other than your job of creating FUD & general noise in the site, what do you contribute. ZERO.
evrn if my or any post is infotmation thst notable or others posted previous, lsat week.it still is valid read, for those who have not seen this yet.
moving in to this week ahead?
We still need update on $$$ source for phase 3. Roche being colborator in the 5 cohorts of the Goblet study, is most obvious canditaed for a business partner or buyout.
Same story for MBc , different business. opportunities. They havec listed as TBD.